Issue 127, 2015
From the journal:

RSC Advances

Correction: Preclinical appraisal of terbutaline analogues in precipitation of autism spectrum disorder

Neha Sharma,a   Swetlana Gautam,a   Uma Devi,b   Manjari Singh,a   Jitendra K. Rawat,a   Nikunj Sethi,c   Shubhini A. Sarafa  and  Gaurav Kaithwas*a  

* Corresponding authors

a Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226 025, U.P., India
E-mail: gauravpharm@hotmail.com
Tel: +91-9670204349

b Department of Pharmaceutical Sciences, Faculty of Health Medical Sciences Indigenous and Alternative Medicine, SHIATS-Deemed to be University Formerly Allahabad Agricultural Institute, Naini, Allahabad, U.P., India

c Institute of Pharmacy, Chatrapati Sahuji Maharaj University, Kanpur-208024, India

Abstract

Correction for ‘Preclinical appraisal of terbutaline analogues in precipitation of autism spectrum disorder’ by Neha Sharma et al., RSC Adv., 2015, 5, 39003–39011.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C5RA90109J
Article type
Correction
Submitted
30 Nov 2015
Accepted
30 Nov 2015
First published
11 Dec 2015
This article is Open Access
Creative Commons BY license

RSC Adv., 2015,5, 104972-104972

Permissions

Request permissions

Correction: Preclinical appraisal of terbutaline analogues in precipitation of autism spectrum disorder

N. Sharma, S. Gautam, U. Devi, M. Singh, J. K. Rawat, N. Sethi, S. A. Saraf and G. Kaithwas, RSC Adv., 2015, 5, 104972 DOI: 10.1039/C5RA90109J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements